FDA licences imatinib mesylate for CML

Targeting cancer: a NOvel way.

Drug discovery today·2003

Stop talking at the back.

Drug discovery today·2003

New ligands for defective receptors.

Drug discovery today·2003

Mistletoe compound enters clinical trials.

Drug discovery today·2003

Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Oncology·2026

Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.

The Lancet. Oncology·2026

Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial.

The Lancet. Oncology·2026

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

The Lancet. Oncology·2026

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026

Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.

The Lancet. Oncology·2026

Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis.

Haematologica·2026

Early Non-Contiguous Pachymeningeal Dissemination of Isocitrate Dehydrogenase (IDH)-Wildtype Giant Cell Glioblastoma: A Rare Finding During Adjuvant Therapy.

Cureus·2026

Erratum: Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2-targeted microbubble-based ultrasound molecular imaging.

Translational cancer research·2026

Arteriovenous fistula-associated angiosarcoma.

Journal of vascular surgery cases and innovative techniques·2026

Atypical baclofen pump catheter dislodgement in spastic cerebral palsy - A case report.

Journal of pediatric rehabilitation medicine·2026

Identification of the Novel HLA-C*03:536:02 Allele in a Chinese Cord Blood Donor.

HLA·2026

Related Experiment Videos

FDA licences imatinib mesylate for CML

Related Concept Videos

Targeting cancer: a NOvel way.

Stop talking at the back.

New ligands for defective receptors.

Mistletoe compound enters clinical trials.

Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial.

Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.

Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial.

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.

Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis.

Early Non-Contiguous Pachymeningeal Dissemination of Isocitrate Dehydrogenase (IDH)-Wildtype Giant Cell Glioblastoma: A Rare Finding During Adjuvant Therapy.

Erratum: Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2-targeted microbubble-based ultrasound molecular imaging.

Arteriovenous fistula-associated angiosarcoma.

Atypical baclofen pump catheter dislodgement in spastic cerebral palsy - A case report.

Identification of the Novel HLA-C*03:536:02 Allele in a Chinese Cord Blood Donor.

Related Experiment Videos

FDA licences imatinib mesylate for CML

Related Concept Videos

Related Articles